Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : JanOne
Deal Size : Undisclosed
Deal Type : Agreement
JanOne strikes agreement with CoreRx
Details : JanOne’s lead drug clinical candidate TV1001SR to treat PAD and associated pain will be manufactured by CoreRX Pharma with phase 2b trials expected to begin Q4 2020.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
June 02, 2020
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : JanOne
Deal Size : Undisclosed
Deal Type : Agreement